Log in
Donate
Search
Close this search box.

Clinical Trial: ECOG-ACRIN EAY191-E4

ECOG-ACRIN EAY191-E4

Status: Temporarily Closed

NCT#05554341

Nilotinib and Paclitaxel in Patients with Prior Taxane-Treated Solid Tumors: A ComboMATCH Treatment Trial
(See required screening study ECOG-ACRIN EAY191)

EAY191-E4 is temporarily closed to accrual, effective January 12, 2024.

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved